» Articles » PMID: 19748740

Role of SIP30 in the Development and Maintenance of Peripheral Nerve Injury-induced Neuropathic Pain

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2009 Sep 15
PMID 19748740
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Using the chronic constriction injury (CCI) model of neuropathic pain, we profiled gene expression in the rat spinal cord, and identified SIP30 as a gene whose expression was elevated after CCI. SIP30 was previously shown to interact with SNAP25, but whose function was otherwise unknown. We now show that in the spinal cord, SIP30 was present in the dorsal horn laminae where the peripheral nociceptive inputs first synapse, co-localizing with nociception-related neuropeptides CGRP and substance P. With the onset of neuropathic pain after CCI surgery, SIP30 mRNA and protein levels increased in the ipsilateral side of the spinal cord, suggesting a potential association between SIP30 and neuropathic pain. When CCI-upregulated SIP30 was inhibited by intrathecal antisense oligonucleotide administration, neuropathic pain was attenuated. This neuropathic pain-reducing effect was observed both during neuropathic pain onset following CCI, and after neuropathic pain was fully established, implicating SIP30 involvement in the development and maintenance phases of neuropathic pain. Using a secretion assay in PC12 cells, anti-SIP30 siRNA decreased the total pool of synaptic vesicles available for exocytosis, pointing to a potential function for SIP30. These results suggest a role of SIP30 in the development and maintenance of peripheral nerve injury-induced neuropathic pain.

Citing Articles

Phylogenetic analysis of mammalian SIP30 sequences indicating accelerated adaptation of functional domain in primates.

Guo N, Raincrow J, Chiu C, Yu L Biochem Biophys Rep. 2024; 37:101631.

PMID: 38188366 PMC: 10771893. DOI: 10.1016/j.bbrep.2023.101631.


SIP30 involvement in vesicle exocytosis from PC12 cells.

Guo N, Yu L Biochem Biophys Rep. 2024; 37:101614.

PMID: 38188363 PMC: 10770524. DOI: 10.1016/j.bbrep.2023.101614.


Early decompression promotes motor recovery after cervical spinal cord injury in rats with chronic cervical spinal cord compression.

Okimatsu S, Furuya T, Miura M, Shiratani Y, Yunde A, Inoue T Sci Rep. 2022; 12(1):14400.

PMID: 36002463 PMC: 9402533. DOI: 10.1038/s41598-022-14723-8.


Interactions between Autophagy, Proinflammatory Cytokines, and Apoptosis in Neuropathic Pain: Granulocyte Colony Stimulating Factor as a Multipotent Therapy in Rats with Chronic Constriction Injury.

Liao M, Yeh S, Lu K, Hsu J, Chao P, Hsu H Biomedicines. 2021; 9(5).

PMID: 34066206 PMC: 8151381. DOI: 10.3390/biomedicines9050542.


Granulocyte Colony Stimulating Factor (GCSF) Can Attenuate Neuropathic Pain by Suppressing Monocyte Chemoattractant Protein-1 (MCP-1) Expression, through Upregulating the Early MicroRNA-122 Expression in the Dorsal Root Ganglia.

Liao M, Hsu J, Lu K, Chao P, Cheng M, Hsu H Cells. 2020; 9(7).

PMID: 32664488 PMC: 7408430. DOI: 10.3390/cells9071669.


References
1.
Wang X, Zhang Y, Kong L, Xie Z, Lin Z, Guo N . RSEP1 is a novel gene with functional involvement in neuropathic pain behaviour. Eur J Neurosci. 2005; 22(5):1090-6. DOI: 10.1111/j.1460-9568.2005.04282.x. View

2.
Lee H, Safieddine S, Petralia R, Wenthold R . Identification of a novel SNAP25 interacting protein (SIP30). J Neurochem. 2002; 81(6):1338-47. DOI: 10.1046/j.1471-4159.2002.00937.x. View

3.
Beltramo M, Campanella M, Tarozzo G, Fredduzzi S, Corradini L, Forlani A . Gene expression profiling of melanocortin system in neuropathic rats supports a role in nociception. Brain Res Mol Brain Res. 2003; 118(1-2):111-8. DOI: 10.1016/j.molbrainres.2003.08.001. View

4.
Bennett M, Calakos N, Scheller R . Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science. 1992; 257(5067):255-9. DOI: 10.1126/science.1321498. View

5.
Cherny N, Thaler H, Lapin J, Foley K, Houde R, Portenoy R . Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology. 1994; 44(5):857-61. DOI: 10.1212/wnl.44.5.857. View